Takahashi Yoshiaki, Igarashi Masayuki
Institute of Microbial Chemistry (BIKAKEN), Tokyo, Japan.
J Antibiot (Tokyo). 2017 Oct 25. doi: 10.1038/ja.2017.117.
Aminoglycoside antibiotics (AGAs) were developed at the dawn of the antibiotics era and have significantly aided in the treatment of infectious diseases. Aminoglycosides have become one of the four major types of antibiotics in use today and, fortunately, still have an important role in the clinical treatment of severe bacterial infections. In this review, the current usage, modes of action and side effects of AGAs, along with the most common bacterial resistance mechanisms, are outlined. Finally, the recent development situation and possibility of new AGAs in the 'post-antibiotic era' are considered.The Journal of Antibiotics advance online publication, 25 October 2017; doi:10.1038/ja.2017.117.
氨基糖苷类抗生素(AGAs)在抗生素时代初期被研发出来,对传染病的治疗起到了显著的辅助作用。氨基糖苷类已成为当今使用的四大类抗生素之一,幸运的是,它们在严重细菌感染的临床治疗中仍发挥着重要作用。在本综述中,概述了氨基糖苷类抗生素的当前使用情况、作用方式和副作用,以及最常见的细菌耐药机制。最后,探讨了“后抗生素时代”新型氨基糖苷类抗生素的最新发展情况及可能性。《抗生素杂志》在线优先发表,2017年10月25日;doi:10.1038/ja.2017.117